文献速递介入技术与安全DSA

IO1-UK:一项重新评估英国介入肿瘤学服务提供情况的横断面研究

IO1-UK: a cross-sectional study to re-evaluate the provision of interventional oncology services across the United Kingdom.
PubMed 文献 · Clin Radiol · 2025-11-20

该研究通过电子调查工具对英国所有介入放射科进行横断面多中心调查,使用皇家放射科医师学院分类定义介入肿瘤学操作,并与2016年调查数据比较。169家医院委员会中132家(78%)有介入放射科,其中49%(65/132)同时提供疾病修饰性和支持/症状性操作,51%(67/132)仅提供支持/症状性操作;与2016年相比,疾病修饰性操作仅适度增加,增幅最大为经动脉化疗栓塞(+9%)、选择性内放射治疗(+7%)和肾消融(+8%)。结论指出过去8年英国介入肿瘤学服务在支持和疾病修饰领域仅 marginally 增长,亟需识别和解决障碍。

要点

  • 英国132家拥有介入放射科的医院委员会中,仅49%(65/132)同时提供疾病修饰性和支持/症状性介入肿瘤学操作。
  • 与2016年相比,疾病修饰性操作增幅最大为经动脉化疗栓塞(+9%)、选择性内放射治疗(+7%)和肾消融(+8%)。
  • 过去8年英国介入肿瘤学服务在支持和疾病修饰领域仅 marginally 增长。

核心结论

  • 过去8年英国介入肿瘤学服务在支持和疾病修饰领域仅 marginally 增长,亟需识别和解决障碍以确保民众受益于现代循证介入肿瘤学治疗。

研究设计与样本

  • 横断面多中心研究,通过UNITE Collaborative使用电子调查工具对英国所有介入放射科进行调查,使用皇家放射科医师学院分类定义介入肿瘤学操作,并与2016年调查数据比较;169家医院委员会受邀,132家(78%)有介入放射科,29家(17%)无介入放射科,8家(5%)未回复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: This study aims to survey the provision of Interventional Oncology (IO) services in the UK and compare the results to survey data collected in 2016.

MATERIALS AND METHODS: A cross-sectional multicentre study of the provision of IO services was conducted across all interventional radiology (IR) departments in the UK. Data were collected using an electronic survey tool and executed via the UNITE Collaborative. IO procedures were defined using the Royal College of Radiologists classification categories. For each IR department information regarding demographic details, current IO procedures, equipment, and relevant infrastructure was collected. Thereafter, responses were compared to survey data collected in 2016.

RESULTS: A total of 169 hospital boards were invited to participate, 132 (78%) of which responded stating they had an IR department, while 29 (17%) responded stating they had no IR department and 8 (5%) provided no response. Of the hospital boards with IR departments, 49% (n=65/132) provided both disease-modifying and supportive/symptomatic procedures and 51% (n=67/132) offered only supportive/symptomatic procedures. Compared to 2016, there was a modest increase in the provision of disease-modifying procedures with the largest growth seen in transarterial chemoembolisation (+9%), selective internal radiation therapy (+7%), and renal ablation (+8%).

CONCLUSION: Over the last 8 years, the provision of IO services across the UK has only marginally grown in both supportive and disease-modifying domains. This study highlights the urgent need to identify and address barriers preventing access to IO procedures to ensure the UK population can benefit from modern, evidence-based IO care.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Velazquez-Pimentel D, Pancholi J, Jenkins P, et al. IO1-UK: a cross-sectional study to re-evaluate the provision of interventional oncology services across the United Kingdom. Clin Radiol. 2025. PMID: 41558909. doi:10.1016/j.crad.2025.107185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。